Optimized Camera-based Patient Positioning in CT

August 29, 2022 updated by: Dr. Panagiota Manava

Optimized Camera-based Patient Positioning in CT: Impact on Radiation Exposure.

To evaluate the effect on radiation dose using intelligent camera positioning in comparison to manual positioning by the radiology assistant.

Study Overview

Status

Completed

Conditions

Detailed Description

The positioning of the patient at the beginning of every CT examination has an major influence on the image quality and especially on the respective effective patient dose in the CT scan. If the patient position is closer to the X-ray tube, the patient dose increases significantly and if the vertical patient position is chosen too far away from the X-ray tube, the applied dose decreases, but also the image quality.

In a retrospective observational study, patients were examined on the CT scanner Somatom X.Cite and divided into two groups, one group was with intelligent camera positioning and the other with manual positioning.

The patients received their CT scan at the Institute Radiology and Nuclear Medicine at the Nuremberg North Hospital strictly according to the clinical indication and without influence of the study.

Study Type

Observational

Enrollment (Actual)

3118

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Nuremberg, Bavaria, Germany, 90419
        • Institute of Radiology and Nuclear Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients of a primary care clinic

Description

Inclusion Criteria:

Only patients with a clinical indication for a CT Scan

Exclusion Criteria:

renal insufficiency, manifest hyperthyroidism and pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
experimental group
patients positioned with 3D camera
control group
patients positioned by experienced radiology assistants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effective dose
Time Frame: 10 months
the absorbed dose to different organs of the body
10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Michael M. Lell, Prof. Dr., Department of Radiology and Nuclear Medicine, Klinikum Nuernberg, Paracelsus Medical University, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

May 24, 2022

Study Completion (Actual)

May 24, 2022

Study Registration Dates

First Submitted

November 14, 2021

First Submitted That Met QC Criteria

November 14, 2021

First Posted (Actual)

November 26, 2021

Study Record Updates

Last Update Posted (Actual)

September 1, 2022

Last Update Submitted That Met QC Criteria

August 29, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CT_2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radiation Dosage

3
Subscribe